About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04102839

PWS Outcomes Assessment Study

This is a longitudinal study during which qualitative interviews will be conducted with caregivers of Soleno C601/C602 study subjects. There is an additional option for caregivers to collect video dat...

Lead sponsor: Soleno Therapeutics, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Soleno Therapeutics, Inc.

Collaborators

Casimir Trials

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Eligible caregivers must:
•Be willing and able to provide informed consent in English
•Care for a C601/C602 trial subject or potential trial subject
•Have access to a smartphone or the internet
•Be able to converse in English
•Eligible PWS participants for the optional daily life video capture must:
•Be willing and able to provide informed consent or assent.
•Be enrolled in the C601/C602 trial
•Be able to converse in English
•Have a caregiver who has access to an Apple or Android smartphone or has internet access and is willing to use a wi-fi-only device to record and upload videos
•Have a caregiver who is willing and able to record activity videos

Exclusion Criteria

•n/a

Related studies

RECRUITINGPhase 2

A Study of CSTI-500 in Patients With Prader-Willi Syndrome

NCT07348601 · Prader-Willi Syndrome

Impact of Bright Light Therapy on Prader-Willi Syndrome

NCT05939453 · Prader-Willi Syndrome, Excessive Daytime Sleepiness, and more

Institutional Registry of Rare Diseases

NCT06573723 · Rare Diseases, Amyloidosis, and more

RECRUITINGPhase 1/2

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

NCT06239116 · Hypothalamic Obesity, Prader-Willi Syndrome, and more

Register of Patients With Prader-Willi Syndrome

NCT02829684 · Prader-Willi Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 4, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment59

Start dateJul 2019

Last updatedNov 4, 2024

Condition

Prader-Willi Syndrome

Locations shown

Casimir Trials

Plymouth, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 4, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions